Expression of RPS11 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS11 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3336.27

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3876.6

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	10434.1
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	9096.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	8756.7
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	8204.3
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	7677.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	7503.3
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	7479.9
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	6909.1
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	6859.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	6478.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	6409.6
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	6218.3
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	6210.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	6177.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	6174.7
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	6152.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	5571.7
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5557.3
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	5496.6
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	5428.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	5356.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	5342.1
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	5229.6
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	5223.2
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	5154.0
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	4900.7
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	4879.8
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	4816.4
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	4708.4
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	4686.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	4645.1
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	4613.6
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4568.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	4520.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	4513.7
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	4414.6
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4351.1
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	4341.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	4315.2
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	4313.7
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	4289.0
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	4239.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	4086.8
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	4086.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	4073.2
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	4070.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	4065.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	4015.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3958.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	3932.7
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3929.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	3926.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	3914.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3913.5
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	3900.9
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	3899.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	3894.3
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3861.4
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	3854.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3849.0
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	3813.0
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3808.7
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3783.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	3765.5
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	3756.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	3749.8
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	3734.8
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3719.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3699.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	3633.5
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3610.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3570.3
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3568.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	3543.1
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	3465.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	3447.4
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	3418.5
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	3413.2
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3395.9
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	3389.2
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	3373.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3371.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	3339.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	3336.3
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	3305.5
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	3302.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	3293.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	3279.9
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3258.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	3256.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	3229.4
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	3199.8
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	3166.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	3125.3
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3047.9
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	3034.7
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2980.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2979.3
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2952.8
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2949.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	2902.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2894.6
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2882.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2827.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2809.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2808.1
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2802.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2784.2
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2770.5
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2692.7
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	2675.7
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2667.8
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2665.2
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2650.4
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2646.6
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	2643.0
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2611.1
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2602.0
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	2501.6
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2404.3
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2373.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2349.6
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2342.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2331.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	2280.2
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2265.5
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2206.9
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2200.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	2132.0
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	2106.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2105.6
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2080.4
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2062.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1928.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1870.9
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1868.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1842.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1774.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1577.1
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1575.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1573.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS11 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1666.69

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1815.3

Number of samples

Samples

Sample	Description	pTPM
AK133	N, NA, stage:NA, dead, 360 days	3298.4
AK074	N, NA, stage:NA, alive, 300 days	2942.1
AK139	N, NA, stage:NA, dead, 270 days	2925.7
AK043	N, NA, stage:NA, alive, 660 days	2804.8
AK165	N, NA, stage:NA, alive, 360 days	2691.8
AK231	N, NA, stage:NA, dead, 240 days	2670.0
AK178	N, NA, stage:NA, dead, 240 days	2589.9
AK098	N, NA, stage:NA, dead, 660 days	2546.8
AK066	N, NA, stage:NA, alive, 960 days	2414.6
AK072	N, NA, stage:NA, dead, 150 days	2394.3
AK049	N, NA, stage:NA, dead, 180 days	2356.5
AK142	N, NA, stage:NA, alive, 90 days	2344.4
AK185	N, NA, stage:NA, alive, 330 days	2291.9
AK199	N, NA, stage:NA, alive, 1860 days	2243.4
AK156	N, NA, stage:NA, dead, 330 days	2230.0
AK188	N, NA, stage:NA, alive, 420 days	2157.2
AK088	N, NA, stage:NA, dead, 360 days	2103.2
AK053	N, NA, stage:NA, dead, 300 days	2096.4
AK213	N, NA, stage:NA, alive, 2010 days	2082.7
AK236	N, NA, stage:NA, dead, 360 days	2053.9
AK055	N, NA, stage:NA, dead, 240 days	1977.6
AK158	N, NA, stage:NA, dead, 360 days	1965.0
AK123	N, NA, stage:NA, dead, 180 days	1951.6
AK089	N, NA, stage:NA, dead, 330 days	1908.0
AK124	N, NA, stage:NA, alive, 1920 days	1861.6
AK100	N, NA, stage:NA, alive, 960 days	1815.5
AK051	N, NA, stage:NA, dead, 360 days	1767.2
AK173	N, NA, stage:NA, dead, 180 days	1765.5
AK041	N, NA, stage:NA, alive, 810 days	1757.2
AK183	N, NA, stage:NA, alive, 360 days	1701.7
AK068	N, NA, stage:NA, alive, 360 days	1683.5
AK002	N, NA, stage:NA, dead, 570 days	1680.9
AK195	N, NA, stage:NA, dead, 390 days	1652.5
AK134	N, NA, stage:NA, dead, 360 days	1628.9
AK030	N, NA, stage:NA, dead, 120 days	1607.0
AK205	N, NA, stage:NA, dead, 120 days	1606.0
AK149	N, NA, stage:NA, dead, 420 days	1549.5
AK015	N, NA, stage:NA, alive, 720 days	1538.2
AK167	N, NA, stage:NA, dead, 180 days	1504.6
AK216	N, NA, stage:NA, dead, 360 days	1488.6
AK117	N, NA, stage:NA, dead, 210 days	1464.6
AK226	N, NA, stage:NA, dead, 360 days	1463.6
AK071	N, NA, stage:NA, dead, 540 days	1431.9
AK103	N, NA, stage:NA, alive, 1320 days	1369.3
AK003	N, NA, stage:NA, dead, 600 days	1338.9
AK081	N, NA, stage:NA, dead, 180 days	1322.9
AK102	N, NA, stage:NA, alive, 1740 days	1296.4
AK091	N, NA, stage:NA, dead, 210 days	1279.5
AK218	N, NA, stage:NA, dead, 180 days	1259.6
AK099	N, NA, stage:NA, dead, 420 days	1250.6
AK085	N, NA, stage:NA, alive, 660 days	1199.7
AK153	N, NA, stage:NA, dead, 240 days	1179.1
AK227	N, NA, stage:NA, alive, 300 days	1096.0
AK079	N, NA, stage:NA, dead, 210 days	1048.3
AK076	N, NA, stage:NA, alive, 660 days	977.1
AK005	N, NA, stage:NA, dead, 240 days	955.5
AK035	N, NA, stage:NA, dead, 210 days	948.7
AK006	N, NA, stage:NA, dead, 360 days	758.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217000004	Tumor	0.8
CPT0206230003	Tumor	0.7
CPT0218690004	Tumor	0.5
CPT0219080004	Tumor	0.5
CPT0182580003	Tumor	0.5
CPT0168380003	Tumor	0.5
CPT0168830003	Tumor	0.5
CPT0205570003	Tumor	0.4
CPT0127480003	Tumor	0.4
CPT0205450004	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0162020003	Tumor	0.4
CPT0206560003	Tumor	0.4
CPT0168080003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0078580003	Tumor	0.3
CPT0175060003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0224390004	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0218330004	Tumor	0.2
CPT0162100003	Tumor	0.2
CPT0221180003	Tumor	0.2
CPT0079790003	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0206000004	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0093450003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0189650004	Tumor	0.2
CPT0125510003	Tumor	0.2
CPT0168590003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0228220003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0217880003	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0205780003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0186100003	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0125570003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0216920008	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0206670004	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0167530003	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0218770003	Tumor	-0.2
CPT0196850003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0204400003	Normal	-0.2
CPT0064650003	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0204350003	Normal	-0.3
CPT0104220003	Tumor	-0.4
CPT0207090003	Tumor	-0.4
CPT0104330003	Tumor	-0.4
CPT0204420003	Normal	-0.4
CPT0204340003	Normal	-0.4
CPT0204390003	Normal	-0.4
CPT0189250003	Tumor	-0.5
CPT0204410003	Normal	-0.5
CPT0190240004	Tumor	-0.5
CPT0204370003	Normal	-0.5
CPT0204380003	Normal	-0.5
CPT0204330003	Normal	-0.5
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA049719
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade